Internal jugular vein thrombosis is a rare condition that can be secondary to malignancy or congestive heart failure, requiring early diagnosis and anticoagulation to prevent fatal complications.
Emphasizes early anticoagulation for rare IJVT; leaves open validation in prospective studies before guiding practice.
Internal Jugular vein (IJV) thrombosis is a rare entity. It is usually secondary to various etiologies such as catheter, malignancy, trauma, infection and hypercoagulable status. Associated malignancies, either known or occult, are also uncommon and not well documented in the etiology of IJV thrombosis. We reported IJV thrombosis with two different pathologies i.e. malignacy and congestive heart failure. The diagnosis of IJV thrombosis was established with Doppler ultrasound and CT scan. These patients were treated low-molecular-weight heparin and oral anticoagulation. Early diagnosis and appropriate management is important to prevent potentially fatal complications from internal jugular vein thrombosis.
No takes yet. Share an insight, caveat, or question.
Uzun et al. (2005) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: